MPH, PhD, Epidemiology, Johns Hopkins Bloomberg School of Public Health
Jennifer Havens is a professor of behavioral science in the University of Kentucky College of Medicine. She is an epidemiologist with an appointment in the Center on Drug and Alcohol Research (CDAR). Her primary research interests include the epidemiology of prescription opioid abuse in rural Appalachia, the comorbidity of substance and mental disorders, and HIV and other infectious complications of drug use. Havens received a R01 from the National Institutes of Health (NIH) to conduct a large-scale hepatitis C treatment study in Perry County, Kentucky. The Kentucky Viral Hepatitis Treatment Project, or KeY Treat, is funded collaboratively through the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), along with a sizable drug donation from Gilead Sciences, Inc. The overarching goal of KeY Treat is to eliminate hepatitis C in Perry County and serve as a model of care for rural areas facing a similar syndemic of opioid abuse and hepatitis C. Havens is also the Principal Investigator on an R01, “Effect of Structural Interventions on Substance Use and HIV/HCV Risk among Rural PWUD,” funded through 2021.
Dr. Havens is a member of the harm reduction team.